<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/abel/Downloads/grobid-0.5.6/grobid-home/schemas/xsd/Grobid.xsd" xml:space="preserve">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)</title>
			</titleStmt>
			<publicationStmt>
				<publisher />
				<availability status="unknown"><licence /></availability>
				<date type="published" when="2016-06-14">Available online 14 June 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Hongjie</forename><surname>Qiu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Microbiology and Epidemiology</orgName>
								<orgName type="laboratory">State Key Laboratory of Pathogen and Biosecurity</orgName>
								<address>
									<settlement>Beijing, Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shihui</forename><surname>Sun</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Microbiology and Epidemiology</orgName>
								<orgName type="laboratory">State Key Laboratory of Pathogen and Biosecurity</orgName>
								<address>
									<settlement>Beijing, Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Beijing Institute of Basic Medical Sciences</orgName>
								<address>
									<settlement>Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>He Xiao b</roleName><forename type="first">Jiannan</forename><surname>Feng</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Beijing Institute of Basic Medical Sciences</orgName>
								<address>
									<settlement>Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yan</forename><surname>Guo</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Microbiology and Epidemiology</orgName>
								<orgName type="laboratory">State Key Laboratory of Pathogen and Biosecurity</orgName>
								<address>
									<settlement>Beijing, Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wanbo</forename><surname>Tai</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Microbiology and Epidemiology</orgName>
								<orgName type="laboratory">State Key Laboratory of Pathogen and Biosecurity</orgName>
								<address>
									<settlement>Beijing, Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Lindsley F. Kimball Research Institute</orgName>
								<orgName type="institution">New York Blood Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yufei</forename><surname>Wang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Microbiology and Epidemiology</orgName>
								<orgName type="laboratory">State Key Laboratory of Pathogen and Biosecurity</orgName>
								<address>
									<settlement>Beijing, Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Lindsley F. Kimball Research Institute</orgName>
								<orgName type="institution">New York Blood Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lanying</forename><surname>Du</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Lindsley F. Kimball Research Institute</orgName>
								<orgName type="institution">New York Blood Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guangyu</forename><surname>Zhao</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Microbiology and Epidemiology</orgName>
								<orgName type="laboratory">State Key Laboratory of Pathogen and Biosecurity</orgName>
								<address>
									<settlement>Beijing, Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yusen</forename><surname>Zhou</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Microbiology and Epidemiology</orgName>
								<orgName type="laboratory">State Key Laboratory of Pathogen and Biosecurity</orgName>
								<address>
									<settlement>Beijing, Beijing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-06-14">Available online 14 June 2016</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1016/j.antiviral.2016.06.003</idno>
					<note type="submission">Article history: Received 30 March 2016 Received in revised form 19 May 2016 Accepted 12 June 2016</note>
					<note>a r t i c l e i n f o</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>

		<encodingDesc>
			<appInfo>
				<application ident="GROBID" version="0.5.6" when="2020-03-16T22:29+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>		<profileDesc>
			<textClass>
				<keywords>MERS-CoV Receptor-binding domain Humanized monoclonal antibody Protection Treatment Lethal infection</keywords>
			</textClass>
			<abstract>
<div><head>a b s t r a c t</head><p>Middle East respiratory syndrome coronavirus (MERS-CoV) is continuously spreading and causing severe and fatal acute respiratory disease in humans. Prophylactic and therapeutic strategies are therefore urgently needed to control MERS-CoV infection. Here, we generated a humanized monoclonal antibody (mAb), designated hMS-1, which targeted the MERS-CoV receptor-binding domain (RBD) with high affinity. hMS-1 significantly blocked MERS-CoV RBD binding to its viral receptor, human dipeptidyl peptidase 4 (hDPP4), potently neutralized infection by a prototype MERS-CoV, and effectively crossneutralized evolved MERS-CoV isolates through recognizing highly conserved RBD epitopes. Notably, single-dose treatment with hMS-1 completely protected hDPP4 transgenic (hDPP4-Tg) mice from lethal infection with MERS-CoV. Taken together, our data suggest that hMS-1 might be developed as an effective immunotherapeutic agent to treat patients infected with MERS-CoV, particularly in emergent cases.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div><head n="1.">Introduction</head><p>Middle East respiratory syndrome coronavirus (MERS-CoV), first isolated from a Saudi Arabian patient in September 2012 </p><p>MERS-CoV belongs to the Betacoronavirus genus of the coronavirus family </p><p>Vaccines and passive therapeutics are effective approaches against viral infections. In general, vaccines cannot provide immediate prophylactic protection against or treatment of ongoing viral infection. In comparison, passive therapeutics based on neutralizing monoclonal antibodies (mAbs) has emerged as a powerful tool to provide prophylactic and therapeutic protection against viral infection </p><p>We previously developed a murine mAb, Mersmab1, that targets MERS-CoV RBD and potently neutralizes MERS-CoV infection . Here, we humanized Mersmab1 and generated a humanized mAb, hMS-1, which exhibited high affinity RBD binding. We first investigated the activity as well as the mechanism of hMS-1 in neutralizing MERS-CoV cell entry. Second, we evaluated its ability to neutralize emergent MERS-CoV strains. Finally, we demonstrated that single-dose treatment with hMS-1 was able to elicit full protection against lethal MERS-CoV infection in an hDPP4 transgenic (hDPP4-Tg) mouse model. Of note, hMS-1 represents the first mAb reported to exhibit this capacity to protect treated animals from the lethal infection of MERS-CoV.</p></div>
<div><head n="2.">Materials and methods</head></div>
<div><head n="2.1.">Ethics statement</head><p>Animal studies were performed in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals. The animal protocol was approved by the IACUC of the Laboratory Animal Center, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology (Permit number, BIME 2015-0023). All procedures involving MERS-CoV were carried out in an approved biosafety level 3 facility.</p></div>
<div><head n="2.2.">Preparation of recombinant proteins</head><p>MERS-CoV RBD proteins were prepared as previously described </p></div>
<div><head n="2.3.">Generation of humanized mAb hMS-1</head><p>The hMS-1 mAb was generated by humanizing the murine mAb Mersmab1 using a previously described protocol </p></div>
<div><head n="2.4.">Enzyme-linked immunosorbent assay (ELISA)</head><p>The reactivity of hMS-1 and MERS-CoV RBD was detected by ELISA as described . Briefly, ELISA plates were coated overnight at 4 C with His 6 -tagged RBD protein (1 mg/ml) and blocked with 2% no-fat milk at 37 C for 2 h. Serial diluted hMS-1 or trastuzumab control (Roche, Roswell, GA, USA) was added to the plates and incubated at 37 C for 1 h. Horseradish peroxidaseconjugated goat anti-human IgG (1:5,000, Santa Cruz Biotechnology, Dallas, TX, USA) was then added and further incubated at 37 C for 1 h. The reaction was visualized by TMB substrate addition (Invitrogen, Carlsbad, CA, USA) and stopped by 1N H 2 SO 4 . The absorbance at 450 nm was measured using an ELISA plate reader (BioTek, Winooski, VT, USA). The half-maximal effective concentration (EC 50 ) of hMS-1 was calculated using GraphPad Prism 5.01 software (La Jolla, CA, USA). hMS-1 epitope mapping was performed by ELISA as described above except that the ELISA plates were coated with a series of mutant RBD proteins (2.5 mg/ml).</p></div>
<div><head n="2.5.">Surface plasmon resonance (SPR)</head><p>The affinity of hMS-1 binding to the MERS-CoV RBD was assayed using a Biacore T100 instrument (GE Healthcare, Little Chalfont, UK). hMS-1 (5 mg/ml) was immobilized on a CM5 sensor chip with an amine coupling kit. The reference flow cell was treated with amine coupling reagent without exposure to hMS-1. The running buffer was HBS-EP (10 mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA, and 0.05% surfactant P20). His 6 -tagged RBD protein at gradient concentrations (2, 4, 8, 16, and 32 nM) was flowed over the chip surface. The chip was regenerated with 100 mM H 3 PO 4 . The sensorgram was analyzed using BIAevaluation software, and the data were fitted to a 1:1 binding model.</p></div>
<div><head n="2.6.">MERS-CoV neutralization assay</head><p>The MERS-CoV neutralization assay was performed as described </p></div>
<div><head n="2.7.">Flow cytometric analysis</head><p>Determination of the hMS-1 inhibitory ability against the binding between MERS-CoV RBD and hDPP4-expressing Huh-7 cells was performed by flow cytometry as described </p></div>
<div><head n="2.8.">Pseudovirus neutralization assay</head><p>The pseudovirus neutralization assay was performed as described . Briefly, 293T cells were co-transfected with plasmids encoding an Env-defective, luciferase-expressing HIV-1 genome (pNL4-3.luc.RE) and encoding the MERS-CoV spike protein (EMC2012 strain) or MERS-CoV emergent strains with the corresponding RBD mutations, to package pseudotyped MERS-CoVs. Pseudoviruses were incubated with serially diluted hMS-1 at 37 C for 1 h and the mixture was then added to Huh-7 cells pre-plated in 96-well tissue culture plates (10 4 /well) 6 h before inoculation. After 72 h, the cells were lysed with cell lysis buffer (Promega, Madison, WI, USA) and transferred into 96-well luminometer plates. The luciferase activity was determined using an Infinite M1000 luminometer (Tecan, San Jose, CA, USA). ND 50 was calculated using the dose-response inhibition model in GraphPad Prism.</p></div>
<div><head n="2.9.">Multiple sequence alignment of MERS-CoV RBDs</head><p>A total of 278 full-length spike protein sequences were collected from the MERS Coronavirus Database of The Virus Variation Resource </p></div>
<div><head n="2.10.">Animal infection and antiviral therapy</head><p>We used 8e10-week-old female hDPP4-Tg mice to evaluate the hMS-1 passive therapeutic effect against lethal MERS-CoV infection . Following intraperitoneal anesthetization with sodium pentobarbital (5 mg/kg of body weight), mice under lethal virus infection were intranasally inoculated with 10 4.6 TCID 50 MERS-CoV (EMC2012 strain) in 20 ml Dulbecco's modified Eagle's medium (DMEM). After 24 h, the mice were intravenously injected with 2 mg/kg purified hMS-1 or the trastuzumab mAb control. Infected mice were observed for 23 days to calculate the body weight change and survival rate. Additionally, 5 mice were sacrificed from each group on day 3 post-infection and lung tissues were collected for virological detection and histopathological evaluation.</p></div>
<div><head n="2.11.">Viral titer detection</head><p>Viral titer was detected as described . Briefly, mouse lung tissues were homogenized in DMEM plus antibiotics to achieve 10% (w/v) suspensions, which were then titrated on monolayers of Vero cells in quadruplicate. The CPE was observed daily under phase-contrast microscopy for 3 days. The viral titer was calculated by the Reed-Muench method and expressed as log 10 TCID 50 /g of tissue.</p></div>
<div><head n="2.12.">Histopathology analysis</head><p>Collected tissues were immediately fixed in 10% neutral buffered formalin and then embedded in paraffin. Sections (4 mm in thickness) were generated, mounted onto slides, and stained by hematoxylin and eosin (H&amp;E). Histopathological changes were observed using light microscopy. The extent of lung injury was scored according to the levels of degeneration and necrosis of the bronchi and bronchiolar epithelium, infiltration of inflammatory cells, alveoli degeneration and collapse, expansion of the parenchymal wall, hemorrhage, and interstitial edema </p></div>
<div><head n="2.13.">Statistics</head><p>Statistical analyses were performed using GraphPad Prism version 5.01. The significance between survival curves was analyzed by Kaplan-Meier survival analysis with a log-rank test. Other data were analyzed using the 2-tailed unpaired t-test with Welch's correction. p &lt; 0.05 was considered significant.</p></div>
<div><head n="3.">Results</head></div>
<div><head n="3.1.">Humanized mAb hMS-1 binds to MERS-CoV RBD with high affinity</head><p>Humanized mAb hMS-1 was expressed in 293F cells and purified by HiTrap Protein A FF. Reducing and non-reducing SDS-PAGE showed that hMS-1 migrated as a single protein of approximately 180 kDa and dissociated into heavy and light chains of about 50 and 26 kDa under reducing conditions ( </p></div>
<div><head n="3.2.">Humanized mAb hMS-1 neutralizes MERS-CoV infection by blocking the binding of MERS-CoV RBD to the hDPP4 receptor</head><p>The neutralizing activity of hMS-1 against live MERS-CoV infection was determined. hMS-1 could potently neutralize infection of live MERS-CoV (EMC2012 strain) in permissive Vero cells with an ND 50 of 3.34 mg/ml </p></div>
<div><head n="3.3.">Humanized mAb hMS-1 recognizes conserved RBD epitopes and cross-neutralizes MERS-CoV evolutionary strains</head><p>To identify the epitopes on the MERS-CoV RBD recognized by hMS-1, we utilized a panel of mutant RBD proteins generated by mutating the key residues at the MERS-CoV RBD and the hDPP4 binding interface to alanine ; the binding between hMS-1 and the respective mutant RBD proteins was then measured by ELISA as described </p><p>Alignment of 278 full-length spike protein sequences deposited in the NCBI MERS-CoV database illustrated that the RBD epitope recognized by hMS-1 is highly conserved among MERS-CoV emergent isolates ( </p></div>
<div><head n="3.4.">Single-dose treatment of humanized mAb hMS-1 provides full protection from lethal MERS-CoV infection in the hDPP4-Tg mouse model</head><p>Because wild-type mice are not permissive to MERS-CoV infection </p><p>Binding kinetics a EC 50 (mg/ml) b ND 50 (mg/ml) c</p><p>hMS-1 1.82 &#194; 10 6 8.17 &#194; 10 &#192;5 4.47 &#194; 10 &#192;11 1.67 3.34 a The binding kinetics of hMS-1 to MERS-CoV RBD was measured by BIAcore. b The RBD-specific reactivity (EC 50 ) of hMS-1 was determined by ELISA. c The neutralizing activity (ND 50 ) of hMS-1 was determined using a live MERS-CoV-based neutralization assay. which MERS-CoV infection can lead to a fatal outcome. After 24 h following lethal infection of MERS-CoV (10 4.6 TCID 50 EMC2012), hDPP4-Tg mice were intravenously injected with a single-dose (2 mg/kg) of hMS-1 or the trastuzumab mAb control and viral titers, histopathological changes, body weight changes, and survival rates were calculated. Viral titers were measured from mouse lungs at three days following viral infection; these demonstrated that mice receiving hMS-1 treatment exhibited significantly lower viral titers than those receiving the trastuzumab mAb control (p &lt; 0.01) </p><p>The hMS-1-treated hDPP4-Tg mice under lethal MERS-CoV infection exhibited fewer histopathological changes </p></div>
<div><head n="4.">Discussion</head><p>MERS-CoV infects humans with high associated mortality, posing a large threat to public health and reinforcing the urgency to develop effective vaccines and therapeutics. A number of therapeutic mAbs have been applied clinically to prevent and treat viral infections </p><p>Notably, almost all reported MERS-CoV neutralizing mAbs including murine, human, and humanized mAbs, target the RBD </p><p>Our data clearly showed that humanized hMS-1 mAb maintained strong reactivity to the RBD, significantly blocking RBD/ hDPP4 receptor binding and potently neutralizing MERS-CoV infection. As it has been demonstrated that MERS-CoV underwent evolution during the 2012e2015 outbreaks </p><p>Several neutralizing mAbs including LCA60, REGN3051, REGN3048, 4C2h, and m336 have been tested in vivo for their protective efficacy using non-lethal MERS-CoV challenge mouse or rabbit models </p></div><figDesc>Analysis of hMS-1 expression. The expression of hMS-1 was resolved by reducing 12% SDS-PAGE (A) and non-reducing 8% SDS-PAGE (B) respectively, followed by Coomassie blue staining. Prestained protein molecular-weight markers (kDa) (Thermo Scientific) are indicated on the left of each panel.</figDesc><figDesc>hMS-1 blocks the binding between MERS-CoV RBD and the hDPP4 receptor. The blocking effect of hMS-1 on the cell-binding activity of MERS-CoV RBD was determined by flow cytometric analysis. (A) Blockage of Fc-fused MERS-CoV RBD protein binding to Huh-7 cells by 20 mg/ml hMS-1. Black line, Huh-7 cell control; purple line, binding of Fc-fused RBD to Huh-7 cells in the absence of antibody; blue line, irrelevant Trastuzumab mAb control; red line, MERS-CoV RBD binding of Huh-7 cells in the presence of hMS-1. (B) Flow cytometric analysis shows that hMS-1 inhibited the binding between the Fc-fused RBD protein and Huh-7 cells in a dose-dependent manner. The data are presented as the mean percentages of inhibition &#177; SEM (n &#188; 3). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</figDesc><figDesc>Mapping of epitopes recognized by hMS-1 in MERS-CoV RBD. (A) Binding of hMS-1 to RBD mutant proteins as detected by ELISA. (B) Neutralizing activity of hMS-1 to pseudovirus mutants in a pseudovirus-based neutralization assay. Data are presented as the means &#177; SEM (n &#188; 2). Protein and pseudovirus without mutations served as the wild type (WT) controls.</figDesc><figDesc>Therapeutic treatment with hMS-1 limits lung viral replication and alleviates lung injury induced by MERS-CoV infection. (A) Viral titers detected in the mouse lung at day 3 post-infection (n &#188; 5). The data are expressed as the means &#177; SEM. **p &lt; 0.01. The dotted line indicates the limit of detection. (B) Semiquantitative histopathological analysis of H&amp;E-stained lung sections from mice sacrificed at day 3 post-infection (n &#188; 5). The data are expressed as the means &#177; SEM. **p &lt; 0.01. (CeJ) Representative H&amp;E-stained lung sections of hMS-1-and Trastuzumab-treated hDPP4 Tg mice, including locations on the trachea (D, H), vessel (E, I), and interstitial area (F, J) (scale bars, 100 mm for C, G; 50 mm for DeF, HeJ).</figDesc><figDesc>Single-dose treatment of hMS-1 fully protects hDPP4 transgenic mice from lethal MERS-CoV infection. The hDPP4 transgenic mice were administered a single-dose of hMS-1 or the irrelevant Trastuzumab 24 h after lethal infection of MERS-CoV and then monitored for 23 days. (A) Body weight changes of hMS-1-and Trastuzumab-treated mice. Results are expressed as the means &#177; SEM (n &#188; 6). (B) Survival rate (%) of hMS-1-and Trastuzumab-treated mice (n &#188; 6). **p &lt; 0.01.</figDesc><figDesc>Cross-neutralizing activities of hMS-1 against pseudotyped MERS-CoV mutants a . a A pseudovirus-based neutralization assay was performed to evaluate the cross-neutralization of hMS-1 against different MERS-CoV isolates. Pseudotyped MERS-CoV</figDesc></body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgements</head><p>This work was supported by the China National Program of Infectious Disease fund 2014ZX10004001004, an NIH grant (R21AI109094), and an intramural fund of the New York Blood Center (NYB000348). The authors declared no conflict of interest.</p></div>
			</div>

			<div type="annex">
<div><head>Appendix A</head><p>MERS-CoV isolates for multiple sequence alignment. A total of 278 full-length of spike proteins of MERS-CoV isolates were collected for multiple sequence alignment. GenBank Accession numbers of collected sequences are listed as follows. AIZ74439; AHL18090; ALS20350; AGH58717; AHY21469; AKM76239; AHY22565; ALJ54461; ALR69641; AHX00711; AHX00721; AHX00731; AHY22555; ALJ54472; ALA49649; AKN24812; ALB08311; ALB08322; ALJ54451; ALJ54455; ALJ54490; ALJ54456; AJG44069; AIY60578; AJG44058; AJG44091; AKM76229; AJG44080; ALA49803; ALA49814; ALJ54474; ALA49671; AHI48528; AKL59401; AKN24803; ALA49660; ALJ54471; ALJ54517; ALJ54495; AJG44102; AJG44113; ALJ54452; ALW82753; AIZ74433; AHB33326; AIZ74417; AIZ74450; AJG44124; ALT66870; ALT66880; AIY60518; AIY60538; AIY60548; AIY60558; AIY60568;</p><p>AIY60588; AIY60528; AHI48550; AGN52936; AFS88936; AGV08390; AFY13307; AGG22542; AHE78097; AHE78108; AHI48594; AHI48605; AHN10812; AHI48583; ALA49374; ALA49693; ALA49704; AHZ58501; AID55073; AKN24749; AKN24758; AKN24767; AKN24776; AKN24785; AKN24794; AKN24821; AKN24830; ALA49396; ALA49407; ALA49418; ALA49429; ALA49836; ALA49902; ALA49946; ALA50067; ALA49385; ALA49550; ALA49561; ALA49572; ALA49616; ALA49627; ALA49638; ALA49682; ALA50034; ALA50045; ALJ54475; ALJ54477; ALJ54478; ALJ54479; ALJ54480; ALJ54493; ALJ54450; ALJ54481; ALJ54484; ALJ54486; ALJ54496; ALW82691;</p><p>ALJ54518; ALA49341; ALJ54446; ALJ54468; AGN70929; AGN70951; AGN70962; AGN70973; AGV08444; AGV08480; AGV08535; AGV08546; AGV08558; AGV08573; AHI48517; AGV08492; ALA49473; ALA49495; ALA49462; ALA49484; ALA49506; ALA49517; ALA49528; ALA49539; ALA49583; ALA49594; ALA49605; ALA49715; ALA49726; ALA49737; ALA49748; ALA49759; ALA49770; ALA49781; ALA49792; ALJ54502; AID55066; AID55067; AID55068; AID55069; AID55070; AID55071; AID55072; AHZ64057; AIZ48760; ALJ54501; ALD51904; AGV08467; AHX71946; AHY22545; AJD81440; ALA49363; ALA49451; ALJ54453; ALJ54467; ALJ54491; ALJ54500; ALJ54508; ALJ54512; ALJ54516; ALJ54521; ALW82742; AGV08379; AGV08408; AGV08584; ALJ54520; AHC74088; AHC74098; ALA49352; ALJ54463; ALA49957; ALA49968; ALB08246; ALB08257; ALJ54458; ALJ54483; ALJ54488; ALJ54497; AGV08455; AHI48539; AHI48561; AKI29255; AKI29265; AKI29275; AKI29284; ALJ54441; ALJ54442; ALJ54443; ALB08267; ALB08278; ALB08289; ALB08300; ALJ54448; ALJ54465; ALJ54466; AHI48572; AHY22525; AHY22535;</p><p>AID50418; AJD81451; AKJ80137; AKK52582; AKK52592; AKK52602; AKK52612; AKQ21055; AKQ21064; AKQ21073; ALA49440; ALA49825; ALA49847; ALA49858; ALA49869; ALA49880; ALA49891; ALA49913; ALA49924; ALA49935; ALA49979; ALA49990; ALA50001; ALA50012; ALA50023; ALA50056; ALJ54444; ALJ54445; ALJ54447; ALJ54449; ALJ54454; ALJ54457; ALJ54459; ALJ54460; ALJ54462; ALJ54464; ALJ54469; ALJ54470; ALJ54473; ALJ54476; ALJ54482; ALJ54485; ALJ54487; ALJ54489; ALJ54492; ALJ54494; ALJ54498; ALJ54499; ALJ54503; ALJ54504; ALJ54505; ALJ54506; ALJ54507; ALJ54509; ALJ54510; ALJ54511; ALJ54513; ALJ54514; ALJ54515; ALJ54519; ALW82636; ALW82647; ALW82658; ALW82669; ALW82680; ALW82709; ALW82720; ALW82731.</p></div>
<div><head>Appendix. BSupplementary data</head><p>Supplementary data related to this article can be found at http:// dx.doi.org/10.1016/j.antiviral.2016.06.003.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bonavia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Zelus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Wentworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Talbot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Holmes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Production of functional chimaeric mouse/human antibody</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Boulianne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hozumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shulman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">312</biblScope>
			<biblScope from="643" to="646" unit="page" />
			<date type="published" when="1984" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Virus variation resourcedrecent updates and future directions</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Brister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Zhdanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ostapchuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Chetvernin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kiryutin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zaslavsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kimelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Tatusova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Coleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Goicochea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Frieman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. General Virol</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope from="408" to="412" unit="page" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus</title>
		<author>
			<persName><forename type="first">D</forename><surname>Corti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pedotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Simonelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agnihothram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fernandez-Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Foglierini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Agatic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vanzetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gopal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Langrish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sallusto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Baric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Varani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zambon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanzavecchia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U. S. A</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cotten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kellam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Al-Rabeeah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Q</forename><surname>Makhdoom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Assiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Al-Tawfiq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Alhakeem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Madani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Alrabiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Hajjar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Alnassir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Albarrak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Flemban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Balkhy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Alsubaie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Palser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bashford-Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rambaut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Zumla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">A</forename><surname>Memish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>De Groot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Baric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Drosten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Enjuanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Fouchier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Galiano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Gorbalenya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">A</forename><surname>Memish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Snijder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zambon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ziebuhr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope from="7790" to="7792" unit="page" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note>Lancet</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The spike protein of SARS-CoV d a target for vaccine and therapeutic development</title>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B.-J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Microbiol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope from="226" to="236" unit="page" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin</title>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B.-J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Liddington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines</title>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Kou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-T</forename><forename type="middle">K</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein</title>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Kou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope from="7045" to="7053" unit="page" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">MUSCLE: multiple sequence alignment with high accuracy and high throughput</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Edgar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Geng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Houser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gretebeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ying</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Lamirande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Bock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Dimitrov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Subbarao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">213</biblScope>
			<biblScope from="1557" to="1561" unit="page" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Transl. Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope from="234" to="259" unit="page" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope from="1237" to="1249" unit="page" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26</title>
		<author>
			<persName><forename type="first">G</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">500</biblScope>
			<biblScope from="227" to="231" unit="page" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragmentsethe importance of immunofocusing in subunit vaccine design</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope from="6170" to="6176" unit="page" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals. Archives Dis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saxena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sharland</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014" />
			<biblScope from="469" to="473" unit="page" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Pre-and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Pascal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Coleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Mujica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kamat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Badithe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fairhurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Strein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berrebi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sisk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Babb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K.-M</forename><forename type="middle">V</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Yancopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Frieman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Kyratsous</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U. S. A</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope from="8738" to="8743" unit="page" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title />
		<author>
			<persName><forename type="first">X</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Audet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fernando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Alimonti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fausther-Bovendo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Aviles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hiatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Morton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Swope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Bohorov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bohorova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Pauly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Velasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pettitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Olinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Whaley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zeitlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Kobinger</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014" />
			<biblScope unit="volume">514</biblScope>
			<biblScope from="47" to="53" unit="page" />
		</imprint>
	</monogr>
	<note>Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(&#8482;). Nature</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Raj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Smits</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Dekkers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dijkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Muth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Demmers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Fouchier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Thiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Drosten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Rottier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Osterhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Bosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Haagmans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">495</biblScope>
			<biblScope from="251" to="254" unit="page" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A simple method of estimating fifty per cent endpoints</title>
		<author>
			<persName><forename type="first">L</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Muench</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hyg</title>
		<imprint>
			<biblScope from="493" to="497" unit="page" />
			<date type="published" when="1938" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S M</forename><surname>Sabir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T Y</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M M</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">E M</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Abo-Aba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Qureshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abu-Zeid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Khiyami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Alharbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Hajrah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Sabir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H Z</forename><surname>Mutwakil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Kabli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A S</forename><surname>Alsulaimany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Obaid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope from="81" to="84" unit="page" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome (SARS): a year in review</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Skowronski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Astell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Brunham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Low</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Petric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Roper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Talbot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Babiuk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Med</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope from="357" to="381" unit="page" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Respir. Cell Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope from="221" to="230" unit="page" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">C</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Agnihothram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stanhope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Avnir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Tallarico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sheehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Baric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Marasco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U. S. A</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells</title>
		<author>
			<persName><forename type="first">X</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Ksiazek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-T</forename><forename type="middle">K</forename><surname>Tseng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope from="9953" to="9958" unit="page" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4</title>
		<author>
			<persName><forename type="first">N</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Arledge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope from="986" to="993" unit="page" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Crystal structure of severe Acute respiratory syndrome coronavirus spike protein fusion core</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Lou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Rao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope from="49414" to="49419" unit="page" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ying</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Prabakaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Dimitrov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope from="7796" to="7805" unit="page" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27</title>
		<author>
			<persName><forename type="first">X</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">13133</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Boheemen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Bestebroer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Osterhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Fouchier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus</title>
		<author>
			<persName><forename type="first">N</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Channappanavar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Garron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tasneem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Mol. Immunol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope from="180" to="190" unit="page" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV</title>
		<author>
			<persName><forename type="first">G</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">K M</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B.-J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virol. J</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">266</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndromecoronavirus</title>
		<author>
			<persName><forename type="first">G</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Kou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">145561</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title />
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L M</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S M</forename><surname>Peiris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
	<note>Epidemiology and cause of severe acute respiratory syndrome (SARS) in</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">People's Republic of China</title>
		<author>
			<persName><surname>Guangdong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<date type="published" when="2003-02" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin</title>
		<author>
			<persName><forename type="first">X</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-H</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K.-H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mcbride</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Paulson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K.-Y</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-F</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-Y</forename><surname>Che</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>